APA (7th ed.) Citation

K, J., SC, M., G, M., A, F., A, F., DJ, M., & CL, S. (2023). Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction. Journal of clinical medicine, 13(1), . https://doi.org/10.3390/jcm13010250

Chicago Style (17th ed.) Citation

K, Jain, McCarley SC, Mukhtar G, Ferlin A, Fleming A, Morris-Rosendahl DJ, and Shovlin CL. "Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction." Journal of Clinical Medicine 13, no. 1 (2023). https://doi.org/10.3390/jcm13010250.

MLA (9th ed.) Citation

K, Jain, et al. "Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction." Journal of Clinical Medicine, vol. 13, no. 1, 2023, https://doi.org/10.3390/jcm13010250.